NextPlat Corp: Unternehmensprofil, Finanzberichte & Marktperformance

mehr Informationen über NextPlat Corp Unternehmen

NextPlat Corp is a global e-commerce and healthcare company. Its e-Commerce Operations segment involves acquiring and leasing, an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online, domestically, and internationally, and enabling customers and partners to optimize their e-commerce presence and revenue, and other related businesses. Its Healthcare Operations segment provides third-party administration, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, compounded medications, tele pharmacy services, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, contracted pharmacy services for 340B covered entities. It provides Mobile Satellite Services solutions for satellite-enabled voice, data, personnel and asset tracking, Machine-to-Machine and Internet of Things connectivity services.

NextPlat Corp Informationen



BörsenkürzelNXPL

Name des UnternehmensNextPlat Corp

IPO-datumMar 15, 1999

CEOMr. David Phipps

Anzahl der mitarbeiter162

WertpapierartOrdinary Share

GeschäftsjahresendeMar 15

Addresse3250 Mary St

StadtCOCONUT GROVE

BörseNASDAQ Capital Market Consolidated

LandUnited States of America

Postleitzahl33133

Telefon13055605355

Websitehttps://ir.nextplat.com/

BörsenkürzelNXPL

IPO-datumMar 15, 1999

CEOMr. David Phipps

Führungskräfte von NextPlat Corp



Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Rodney Barreto

Non-Executive Independent Chairman of the Board

2.24M

+36.14%

Mr. David Phipps

President, Chief Executive Officer, Director, Chief Executive Officer - Global Operations

621.79K

+47.42%

Ms. Elizabeth Alcaine

Independent Director

60.57K

--

Mr. Anthony Armas

Independent Director

60.57K

--

Mr. Louis Cusimano

Independent Director

35.43K

-36.08%

Mr. Hector Delgado

Independent Director

24.60K

--

Mr. Douglas S. Ellenoff

Vice Chairman of the Board, Chief Business Development Strategist

--

Mr. Robert Bedwell

Chief Compliance Officer

--

Mr. Michael Glickman

Investor Relations

--

Ms. Amanda L. Ferrio

Chief Financial Officer

--

Name

Name/Position

Position

Aktienbesitz

Veränderung

Mr. Rodney Barreto

Non-Executive Independent Chairman of the Board

2.24M

+36.14%

Mr. David Phipps

President, Chief Executive Officer, Director, Chief Executive Officer - Global Operations

621.79K

+47.42%

Ms. Elizabeth Alcaine

Independent Director

60.57K

--

Mr. Anthony Armas

Independent Director

60.57K

--

Mr. Louis Cusimano

Independent Director

35.43K

-36.08%

Mr. Hector Delgado

Independent Director

24.60K

--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Oct 6

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Pharmacy Prescription And Other Revenue Net Of Pbm Fees

8.17M

61.73%

e-Commerce revenue

4.12M

31.12%

Pharmacy 340B contract revenue

947.00K

22.99%

Nach RegionUSD

Name

Umsatz

Anteil

Europe

1.99M

48.37%

North America

1.28M

31.17%

Asia & Pacific

641.00K

15.56%

Africa

188.00K

4.56%

South America

14.00K

0.34%

Nach Geschäftsbereich

Nach Region

Nach GeschäftsbereichUSD

Name

Umsatz

Anteil

Pharmacy Prescription And Other Revenue Net Of Pbm Fees

8.17M

61.73%

e-Commerce revenue

4.12M

31.12%

Pharmacy 340B contract revenue

947.00K

22.99%

Aktionärsstatistik

Aktualisiert: Fri, Oct 31

Aktionäre

Aktionärstypen

Aktionäre

Anteil

Fernandez (Charles M)

17.69%

Frost Gamma Investments Trust

13.21%

Barreto (Rodney)

8.63%

Keyser (Robert)

3.77%

Phipps (David)

2.39%

Andere

54.31%

Aktionäre

Anteil

Fernandez (Charles M)

17.69%

Frost Gamma Investments Trust

13.21%

Barreto (Rodney)

8.63%

Keyser (Robert)

3.77%

Phipps (David)

2.39%

Andere

54.31%

Aktionärstypen

Aktionäre

Anteil

Individual Investor

34.31%

Corporation

13.21%

Investment Advisor

5.53%

Investment Advisor/Hedge Fund

1.04%

Hedge Fund

0.13%

Venture Capital

0.07%

Andere

45.71%

Institutionelle Beteiligung



Aktualisiert: Wed, Oct 1

Berichtszeitraum

Anzahl der Institutionen

Gehaltenen Aktien

Anteil

Veränderung

2025Q3

34

1.76M

6.77%

+471.08K

2025Q2

43

13.26M

51.07%

+1.66M

2025Q1

43

11.85M

60.63%

+595.42K

2024Q4

41

12.22M

47.07%

+1.42M

2024Q3

33

11.44M

52.41%

+839.72K

2024Q2

34

11.11M

57.81%

+518.97K

2024Q1

35

11.08M

58.38%

+876.45K

2023Q4

35

10.68M

71.96%

+7.69M

2023Q3

37

11.28M

76.50%

+7.16M

2023Q2

40

11.24M

76.32%

+7.16M

Aktionärsaktivitäten



Name

Gehaltenen Aktien

Anteil

Veränderung

Änderung%

Datum

Fernandez (Charles M)

4.59M

17.69%

+687.04K

+17.59%

Apr 28, 2025

Frost Gamma Investments Trust

3.43M

13.21%

--

Apr 28, 2025

Barreto (Rodney)

2.24M

8.63%

+594.49K

+36.14%

Apr 28, 2025

Keyser (Robert)

979.50K

3.77%

+78.75K

+8.74%

Apr 28, 2025

Phipps (David)

621.79K

2.39%

+200.00K

+47.42%

Sep 26, 2025

EverSource Wealth Advisors, LLC

580.69K

2.24%

--

Jun 30, 2025

Geode Capital Management, L.L.C.

223.30K

0.86%

+5.87K

+2.70%

Jun 30, 2025

Hough (Jervis Bennett)

127.67K

0.49%

+127.67K

--

Oct 01, 2024

Ellenoff (Douglas S.)

125.00K

0.48%

--

Apr 28, 2025

Verbundene ETFs



Aktualisiert: Sun, Nov 2

Name

Anteil

iShares Micro-Cap ETF

0%

Fidelity Nasdaq Composite Index ETF

0%

Dimensional US Core Equity 1 ETF

0%

iShares Micro-Cap ETF

Anteil0%

Fidelity Nasdaq Composite Index ETF

Anteil0%

Dimensional US Core Equity 1 ETF

Anteil0%

Dividende



In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.

Datum

Dividende

Stichtag für die Aktienregistrierung

Zahltag

Ex-Dividendentag

Keine Daten

Aktien-Split



Datum

Art

Verhältnis

Keine Daten

Datum

Art

Verhältnis

Keine Daten